Objective: A cross-sectional study was conducted at Muhimbili National Hospital (Tanzania) to determine prevalence of helminthiasis among in-patients with HIV/AIDS. Methodology: After signing an informed consent form, participants answered a sociodemographic and risk factor questionnaire. Fecal specimens from patients with HIV-infected and uninfected patients were screened for intestinal helminthiasis (IHLs) using coprological methods. Results: A total of 146 patients were recruited, of those 66 were HIV-negative while 80 were HIV-negative patients. Thirty-five patients (12 HIV/AIDS and 23 non-HIV/AIDS) had helminthic infections. Hookworms were the most frequently detected helminths among patients living with HIV/AIDS (13.6%) and HIV-negative patients (17.5%), followed by schistosomiasis (9%) detected among HIV-negative individuals only. Conclusion: Prevalence of helminthiases (HLs) was observed to be relatively lower among HIV-infected than uninfected patients, which is ascribable to prophylactic measures adopted for patients with HIV/AIDS. Thus, it is recommended that routine screening for HLs and prophylactic measures should be adopted for the improvement of patients’ health status.
Kam KMGut parasites in general practice in Hong Kong. J Trop Med Hyg. 1994;97:117-120.
2.
Modjarrad K. , Zulu I., Redden DT, Njobvu L., Freedman DO, Vermund SHPrevalence and predictors of intestinal helminthic infections among HIV1-infected adults in an urban. African setting. Am J Trop Med Hyg. 2005;73(4):777-782.
3.
Maizels RMInfections and allergy-helminths, hygiene and host immune regulation . Curr Opin Immunol. 2005;17(6):656-661.
4.
Lwambo NJS , Siza JE, Brookes RS, Bundy DAP , Guyatt H.Patterns of concurrent hookworm infection and schistosomiasis in schoolchildren in Tanzania. Trans R Soc Trop Med Hyg. 1999 ; 93(5):453-502.
5.
Mwambete KD, Kalison N.Prevalence of intestinal helminthic infections among under fives and knowledge on helminthiases among mothers of under fives in Dar es Salaam, Tanzania. East Afr J Public Heath. 2006;3(1):8-11.
6.
Evans E., Jamison D.Economics and the argument for parasitic disease control. Science. 1994;264(5167):1866-1867.
7.
Brown M., Mawa PA, Kaleebu P., Elliott M.Helminths and HIV infection epidemiology observations on immunological hypothesis . Parasite Immunol. 2006;28(11):613-623.
8.
World Bank.World Development Report: Investing in Health. Oxford: Oxford University Press; 1993.
9.
Feitosa G., Bandeira AC, Sampaio DP, Badaro R., Brites C.High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Braz J Infect Dis. 2001;5(6):339-344.
10.
Awole M., Gebre-Selassie S., Kassa T., Kibru G.Prevalence of intestinal parasites in HIV-infected adult patients in Southwestern Ethiopia. Ethiop J Health Dev. 2003;17(1):71-78.
11.
Fontanet AL , Sahlu T., Rinke de Wit T., et al. Epidemiology of infections with intestinal parasites and human immunodeficiency virus (HIV) among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol . 2000;94(3):269-278.
12.
Bundy DAP , Sher A., Michael E.Good worms of bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol Today. 2000;16(7):273-274.
13.
Bentwitz Z.Can eradication of helmintic infections change the face of AIDS and tuberculosis? Immunol Today. 1999;20(11): 485-487.
14.
Bentwich Z. , Weisman Z., Moroz C., Bar-Yehuda S., Kalinkovich A.Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exper Immunol . 1996;103(2):239-243.
15.
Actor J., Shirai M., Kullberg M., Buller R., Sher A., Berzofsky J.Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A. 1993;90(3): 948-952.
16.
Brady MT, O-Neill SM, Dalton JP, Mills KHFasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun. 1999;67(10):5372-5378.
17.
Elias D., Akuffo H., Thors C., Pawlowski A., Britton S.Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol . 2005;139(3):398-404.
18.
Porto AF, Neva F., Bittencourt H., et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001;23(9):503-507.
19.
Loufty M., Wilson M., Keystone J., Kain K.Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66(6): 749-752.
20.
Heyworth MFParasitic diseases in immunocompromised hosts. Cryptosporidiosis, isosporiasis and strongyloidiasis. Gastroent Clin North Am. 1996;25(3):691-707.
21.
Morris AJ, Wilson ML, Reller LBApplication of rejection criteria for stool ovum and parasite examinations . J Clin Microbiol. 1992;30(12):3213-3216.
22.
Kalinkowich A., Weisman Z., Greenberg Z., et al. Decreased CD4 and decreased CD8 counts with T-cell activation is associated with chronic helminth infection. Clin Exp Immunol. 1998 ; 114(3):414-421.
23.
Kaminsky RG , Soto RJ, Campa A., Baum MKIntestinal parasitic infections and eosinophilia in an human immunedeficiency virus positive population in Honduras. Mem Inst Oswaldo Cruz. 2004 ; 99(7):773-778.
Steketee RWSupplement: nutrition as a preventive strategy against adverse pregnancy outcomes. Pregnancy, nutrition and parasitic diseases . J Nutr. 2003;133(5):1661S-1667S.
26.
Dickson R., Awasthi S., Williamson P., Demellweek C., Garner P.Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials . BMJ. 2000;320(7251):1697-1701.
27.
Elliott AM, Mpairwe H., Quigley M., et al. Helminth infection during pregnancy and development of infantile eczema. JAMA. 2005; 294(16):2032-2034.
28.
Hosseinipour MC, Napravnik S., Joaki G., et al. HIV and parasitic infections and the effect of treatment among adult outpatients in Malawi. J Infect Dis. 2007;195(9):1278-1282.
29.
Tanzania Commission for AIDS (TACAIDS) , National Bureau of Statistics (NBS), and ORC Macro. Tanzania HIV/AIDS Indicator Survey 2003-04. Calverton, MD: TACAIDS, NBS, and ORC, Macro; 2005.
30.
Bu Figueroa E. , Fernández J., Alvarado T.Características epidemiolόgicas y clínicas de los 100 primeros casos de SIDA en Honduras. Med Clin. 1992;1(1):9-13.
31.
Cook RTT cell modulations in human alcoholics. In: Watson RR, ed. Alcohol, Drug Abuse, and Immune Functions. CRC Press; 1995:57-86.
32.
Watson RR, Borgs P., Witte M., et al. Alcohol, immunomodulation, and disease. Alcohol Alcohol. 1994;29(2):131-139.
33.
Feierman DE , Melinkov Z., Nanji AAInduction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcohol Clin Exp Res. 2003;27(6):981-988.
34.
Cummins D., Garscia R., Trotter G., Turham G., Moussa M.; International Conference on AIDS (15th: 2004: Bangkok, Thailand). Smoking cessation program and HIV positive clients. Int Conf AIDS . July 11-16, 2004; 15: Doc 12133.
35.
Miguez-Burbano HJ, Burbano X., Ashkin D., et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;81(1):39-43.
36.
Feldman JG, Minkoff H., Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006;96(6):1060-1065.
37.
Park LP, Margolick JB, Giorgi JV, et al. Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men: the Multicenter AIDS Cohort. J Aquir Immune Defic Syndr Hum Retrovirol. 1992;5(11):1124-1130.
38.
Wewers MD, Diaz PT, Wewers ML, Lowe MP, Nagaraja HN, Clanton TLCigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med. 1998 ;158(5 pt 1):1543-1549.
39.
Nieman RB, Fleming J., Coker RJ, Harris JR, Mitchell DMThe effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS. 1993;7(5):705-710.
